| INTRODUC TI ON
End-stage organ failure is a leading cause of death in the United States. Together, chronic liver and kidney disease cause the deaths of over 80 000 Americans each year. Deceased donor organ transplantation provides a vital therapy for those patients able to receive it. However, deceased donor organ availability is inadequate for the number of patients needing transplantation. Living donation provides important access to transplantation with liver and kidneys. In the United States, grafts from living donors make up about 5% of the allografts used in liver transplantation and constitute about 30% of kidney grafts. 1, 2 Throughout the world, nearly 30 000 people undergo organ transplantation annually with a living donor. 3, 4 The ability to use living donor organs is limited by access to a compatible donor. However, willing living donors are not a match to their intended recipients 30% of the time due to ABO incompatibility or positive cross-matches. 5 Paired exchanges for kidneys are thus utilized to enable transplantation in cases of incompatibility between donor and recipient. 6, 7 In the simplest case, a donor/recipient dyad that is mismatched by blood type is then paired with a second donor/recipient dyad with the appropriate blood type. These exchanges need not be confined to 2 pairs; they can also involve chains, 8, 9 and can include compatible donor/recipient pairs who agree to participate in exchanges with incompatible donor/recipient pairs. 10 Paired-exchange programs have facilitated thousands of kidney transplants in the United States and have been used in liver transplants in Asia. 11 These exchange programs work well when willing donors cannot donate to their intended recipient because of blood group or antibody incompatibility. However, sometimes a willing donor is found to have contraindications to donation in the organ that the recipient needs.
For example, kidney donors can be ruled out due to a mild reduction in GFR, a single kidney, or increased risk of developing renal disease associated with family history. Among people who undergo evaluation, about 60%-70% of kidney donor declinations are due to medical reasons in a willing donor and about one-third of those are kidney specific. 12 In our living donor liver program, one-fourth of donors are excluded because of inadequate graft volume for the recipient or because of anatomic situations where the left lobe is less than 30% of liver volume, which would leave an inadequate remnant after donation. 13 The Toronto group reported that during the time they performed 570 living donor living transplantations (LDLTs), another 307 donors had unsuitable anatomy 14 and thus were not able to donate to their intended recipients.
Paired exchanges for different organs have not been performed, in large part due to the disparity of risks involved in kidney and liver donation procedures. However, over the last 20 years, much has been learned about kidney and liver donation and the risks involved.
Progress in reducing the morbidity involved in live donor procurement raises the question of whether paired exchanges using liver and kidney donor/recipient pairs could be an ethically sound practice, appropriate to increase the number of organs available for transplantation.
Because organ-specific issues are a frequent cause for willing donors not to proceed to donation, trans-organ exchanges could save the lives and improve the well-being of many people needing organs. Such exchanges are likely to facilitate timely receipt of a needed organ and thus reduce the risk of death and minimize suffering. Availability of a living donor, for instance, has been associated with a greater than 50% reduction in death among liver patients on the waiting list and 66% reduction in death among kidney patients. 15, 16 In trans-organ exchanges, the willing donor of a kidney recipient who has contraindications to donating a kidney, but is appropriate for liver donation, would donate a lobe of his or her liver, while the donor associated with the liver recipient and who has a contraindication to donating a lobe of liver, but is appropriate for kidney donation, would donate a kidney (see Figure 1 ). For instance, one could imagine a willing kidney donor with a single kidney who could donate to a liver recipient, while a liver donor with a 73/27 lobar distribution would donate a kidney to a recipient who needs it.
The purpose of this article is to explore some of the ethical concerns that trans-organ exchange programs pose. Given the potential benefits to the many patients who need organs and to their families, we hope that this discussion can both open the debate about the technical feasibility and ethical soundness of paired trans-organ exchanges as well as promote empirical research needed to guide all stakeholders involved in this potential type of living organ donation.
| E THI C AL ISSUE S
In the United States, the National Organ Transplant Act (NOTA), prohibits the exchange of organs for valuable consideration. 17 In light of paired exchanges, the Charlie W. Norwood Living Organ Donation Act specifically amended NOTA to allow for "human organ paired donation" and does not specify that the organs must be the same. 
| Unbalanced donor risks
In current exchange programs, where different participants donate the same organ, donors incur similar risks of harm. A distinct ethical concern in liver-kidney exchanges is that liver donors will be exposed to greater risks than kidney donors are. The short-term morbidity for both liver and kidney donors includes bleeding requiring blood transfusion, bowel injuries, incisional hernias, and bowel obstruction. 22, 23 The risk of death for kidney donors is estimated to be about 1 in 3000 24 whereas the risk of death for liver donation surgery is about 1 in 500, 4, 25 although it has been reported as low as 1 in 5000. 26 A recent registry study of nearly 15 000 donor nephrectomies identified a perioperative complication rate of 16.8% of which 7.3% were Clavien-Dindo grade III or higher. 27 Liver donation has been reported to have a complication rate between 12 and 40% of which 3.5-3.8% were Clavien-Dindo grade 3 or higher. 23, 26, 28, 29 The recovery period for kidney donors is usually in the 3-to 4-week range. On the other hand, the recovery period for liver donation is generally twice that for kidney donation, with a 6-to 10-week range. Kidney donors appear to have a modestly increased risk of end-stage renal disease, 30 whereas evidence from the A2ALL, the 9-center living liver donor consortium, shows that there is very little or no increased risk of liver failure in liver donors. 23 Furthermore, liver regeneration appears to achieve volumetric recovery to over 90% of the original volume, on average. This contrasts with renal recovery in donors, which is lower. 31 Liver donation risks may be mitigated by using smaller allografts and leaving the donor with a more substantial liver remnant. 32 Most liver transplantations involving adult recipients use right lobe donor grafts. 33 In a recent series of 5202 liver donors, more than 80% were right lobe donors. 26 In addition, it is not clear that left lobe donors have a lower morbidity than right lobe donors. 23 Therefore it may be most appropriate to discuss right lobe liver donation and kidney donation.
The practice of living donation imposes health risks on donors for the benefit of recipients. Usually, imposing risks on living donors is thought to be justified when donor safety is reasonably ensured, Appropriately informed donors might believe that the mortality and quality of life benefits to their loved one justify the differences in the risks that donors assume.
| Valid informed consent
Exposing organ donors to risks requires not only that risks are reasonable and balanced in relation to potential benefits but also that donors give voluntary and informed consent. The ethical requirement to obtain informed consent is important in any medical intervention, but it is particularly so in the case of living organ donations, a procedure that offers no medical benefits to the donors. 19 Consent is appropriately informed when a capacitated or competent individual, who receives adequate disclosures and understands what has been disclosed, voluntarily consents to the procedure. 39 An adequate disclosure in the context of trans-organ exchanges requires that clinicians provide information that could make a difference to whether donors and recipients wish to participate in such exchanges and that they do so in ways that do not overwhelm donors and recipients. 40 Of course, the need for appropriate disclosure is the same for trans-organ exchanges and cases of same-organ exchanges, or the simple case of living donation. [40] [41] [42] Like in all living organ donations, donors and recipients should be informed of possible outcomes, short and long-term risks, potential health and psychological benefits, financial costs, as well as alternative treatment options available to the recipient. But clinicians will need to pay particular attention to information regarding the unequal risks imposed on the donors in trans-organ donation exchanges. That is, it is not sufficient to give information to each donor and recipient pair about the risks and benefits they will incur, but they should also be informed about the differential risks to which the donors will be exposed. This information, which should be provided in culturally sensitive ways, can be relevant to both recipients and donors when they are deciding about whether to participate in the exchange. 43 Ensuring that donors and recipients understand these differences will be essential for them to be able to give an autonomous authorization. Risks and benefits of paired exchanges may be difficult to specify given the many variables that will be involved, and thus participants should also be made aware of the uncertainty regarding risks and potential benefits. Moreover, variations among institutions in the skills and experience of the transplant team can also complicate disclosure of risk-benefit information in ways that is meaningful to donors and recipients, and such differences should also be disclosed.
But appropriate disclosure and understanding is not sufficient for a valid informed consent. Also necessary is the requirement that individuals provide a free or voluntary authorization. When considering donation, concerns arise that such authorization might be involuntary because potential donors may be subject to various social and emotional pressures. 44, 45 When family members or loved ones are involved, such concerns are even more pressing, as the fear exists that free consent when donating to a loved one is likely to be suspect because donors can be subject to a feeling of moral obligation. 46 However, it seems clear that acting out of a reasonable sense of moral obligation need not at all compromise voluntariness.
Indeed, it can be a way of exercising one's freedom, and although many family members perceive the option to donate as a moral obligation, they do not see it as involuntary. 47 The possibility that people might feel undue pressure to donate is a real concern and one that imposes moral duties on transplant teams to try to minimize by ensuring that they provide potential donors with ample opportunity to say no and that they are attentive to factors that might make it harder for these individuals to feel they can refuse to be a donor. [48] [49] [50] Current psychosocial screening of potential donors aims at least in part to minimize the risks of involuntary consent. But determining voluntariness is not an easy task, and subtle pressures might induce potential donors to participate in living donations in ways that are not fully voluntary.
As with the need for adequate disclosure, concerns about the voluntariness of consent to donation are present in all cases of living donations to love ones. Trans-organ exchanges make these concerns particularly salient. One reason for this is that trans-organ donations make more difficult the possibility of a practice intended to protect the voluntariness of living donors. Transplant teams commonly try to protect potential donors from undue influence by providing a medical excuse or "white lie," which can involve either false information about some medical problem 51 or references to a general lack of suitability. 42 Such an excuse relieves potential donors from the need to participate in living donations but allows them to refuse in a way that is consistent with their desires not to directly decline requests from loved ones who need an organ. This, of course, does not mean that transplant teams cannot put mechanisms in place to try to ensure the voluntary choice of potential donors in ways that also protect them from guilt, shame, or ostracism. 38 The fact that trans-organ donation presents potential donors with more opportunities to be eligible and makes it harder to provide a medical excuse that satisfies family members and allows potential donors to refuse to donate without being blamed, calls for attention to the ways in which various pressures on donors might invalidate consent and for the development of procedures that ensure that potential donors are acting voluntarily. This would require not only a complete medical and psychosocial evaluation of potential donors, but also social changes that can make the option of declining to donate to a loved one more acceptable.
| Effects on deceased organ donation
Insofar as living organ donation presents the potential for serious harm to donors, emphasis should be put on finding ways to obtain more organs from other sources, particularly from deceased donors. Thus, trans-organ exchanges present an ethical challenge to the extent that by increasing the use of living donated organs they can reduce the need to promote other sources of organs. Given the scarcity of organs, however, this concern should result in a push for implementation of policies that better promote deceased organ donation and encourage research on other sources of needed organs without prohibiting or completely discouraging living donations, including paired exchanges. It is also important to point out that living donor renal transplantation is the optimal therapy for end-stage renal disease and yields significantly better results than deceased donor renal transplantation, and thus it would be warranted even if there was a better deceased donor organ supply.
| Withdrawing consent
Because various donors are involved in paired-organ exchanges, it is possible that some donors will withdraw their consent after their loved one has received the needed organ from another donor. This is a concern for organ exchange programs in general and has led some transplantation teams to perform surgeries simultaneously. 56 Although breaks in nonsimultaneous paired-exchange chains occur less commonly than was feared, initiating this practice with simultaneous surgeries might minimize this problem.
Two separate teams present logistical challenges and introduce the need for 2 separate donor evaluations. However, 2 separate teams may contribute to enhancing privacy and confidentiality ad limit the extent to which donor criteria for either organ would be weakened. 
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